• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Outcome After Intracranial Surgery

August 5, 2018
Natalie Stilwell, DVM, MS, PhD

A recent retrospective study examined the frequency of postoperative complications in canine patients after craniotomy or craniectomy.

Intracranial surgery is indicated most frequently in dogs for tumor removal or management of traumatic injury. Surgical patients typically require intensive postoperative care due to increased risk of complications, including aspiration pneumonia and neurologic deterioration.

RELATED:

  • How Canine Brain Cancer Studies Could Help Humans, Too
  • One Health to the Rescue: Intracranial Arteriovenous Malformation in a Dog

Researchers in the United Kingdom recently performed a retrospective study to evaluate survival and postoperative outcome in canine patients after intracranial surgery at a referral center.

Study Design

Advertisement

The investigators identified dogs that underwent intracranial surgery based on findings from physical and neurologic examination, blood work, and magnetic resonance imaging or computed tomography. Patients recovered in the center’s intensive care unit (ICU) and were monitored every 2 hours, repositioned every 4 hours, and administered eye lubrication every 4 hours. To avoid risk of increased intracranial pressure, no neck leads or jugular venipuncture was allowed, and parenteral nutrition was provided until patients regained adequate mentation for assisted feeding.

The investigators performed statistical analyses to determine whether variables such as patient signalment, diagnosis, and surgical details influenced duration of hospitalization, survival to discharge, and development of postoperative complications.

Results

Thirty-one male and 19 female dogs were included in the study, with a median age and weight of 9 years and 25.3 kg, respectively. At presentation, most dogs had 1 or more neurologic abnormalities, including history of seizures (68%), abnormal mentation (40%), proprioceptive deficits (40%), 1 or more cranial nerve deficits (32%), and ataxia of all limbs (30%).

Reasons for intracranial surgery were as follows: neoplasm removal (72%), intracranial empyema (10%), decompression from traumatic injury (8%), excisional biopsy (4%), foramen magnum decompression (4%), and removal of an intracranial arachnoid diverticulum (2%). Eighty-six percent of neoplasms were meningiomas. Surgical approach was temperoparietal (50%), transfrontal (44%), or suboccipital (6%). Mean surgery time was 184 minutes (range, 70-365 minutes).

Two dogs required blood transfusion during surgery due to intracranial hemorrhage, and IV mannitol was administered to 78% of patients during surgery. All dogs received postoperative analgesia in the form of methadone with or without paracetamol, and 54% and 68% of patients received preoperative and postoperative glucocorticoids, respectively, to reduce either vasogenic edema or inflammation.

Survival data were as follows:

  • One dog did not recover from anesthesia due to suspected malignant hyperthermia syndrome.
  • Two dogs developed fatal aspiration pneumonia.
  • One dog that was comatose before surgery died of cardiac arrest 6 days after surgery.
  • Forty-six dogs survived to discharge.

Forty-five percent of dogs showed early postoperative neurologic deterioration that was typically mild. The most common nonneurologic postoperative complication, observed in 12% of dogs, was aspiration pneumonia. Median duration of ICU care and hospitalization was 1 and 5 days, respectively.

Statistical analyses were limited by the high survival rate; however, multivariate models revealed that dogs with nonneurologic complications, higher postoperative glucose, or lower preoperative pulse rate were hospitalized longer than were other dogs.

Major Conclusion

The study concluded that nearly all dogs undergoing intracranial surgery survived to discharge and experienced postoperative complications that were typically short-lived and mild.

Dr. Stilwell received her DVM from Auburn University, followed by a MS in fisheries and aquatic sciences and a PhD in veterinary medical sciences from the University of Florida. She provides freelance medical writing and aquatic veterinary consulting services through her business, Seastar Communications and Consulting.


Advertisement

Latest News

The four-letter word to why you're burning out and feeling unproductive

Merck Manuals recognizes importance of One Health concept

Topical therapy and immunotherapy can save time and frustration with dermatology cases

Texas Tech appoints new faculty member with passion for animal agriculture

View More Latest News
Advertisement